Diversified Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$998K	Buy	44,842 +5,022	+13%	+$120K	0.02%	461
2025 Q4	$1.06M	Buy	39,820 +1,942	+5%	+$46.4K	0.02%	420
2025 Q3	$808K	Buy	37,878 +1,907	+5%	+$45.1K	0.02%	472
2025 Q2	$776K	Hold	35,971	–	–	0.02%	449
2025 Q1	$597K	Buy	35,971 +197	+0.6%	+$3.58K	0.01%	519
2024 Q4	$656K	Buy	35,774 +3,187	+10%	+$51.4K	0.02%	508
2024 Q3	$501K	Buy	32,587 +42	+0.1%	+$701	0.01%	583
2024 Q2	$529K	Buy	32,545 +1,680	+5%	+$27.1K	0.01%	528
2024 Q1	$571K	Buy	30,865 +1,826	+6%	+$45.2K	0.02%	476
2023 Q4	$909K	Sell	29,039 -571	-2%	-$13.6K	0.03%	316
2023 Q3	$617K	Buy	29,610 +2,442	+9%	+$66.3K	0.02%	386
2023 Q2	$651K	Sell	27,168 -5,089	-16%	-$113K	0.02%	385
2023 Q1	$607K	Buy	32,257 +6,411	+25%	+$122K	0.02%	397
2022 Q4	$411K	Sell	25,846 -478	-2%	-$7.47K	0.02%	485
2022 Q3	$431K	Buy	26,324 +15	+0.1%	+$243	0.02%	437
2022 Q2	$371K	Buy	26,309 +5,464	+26%	+$102K	0.02%	500
2022 Q1	$505K	Sell	20,845 -487	-2%	-$11.8K	0.02%	443
2021 Q4	$498K	Sell	21,332 -2,196	-9%	-$44.2K	0.02%	461
2021 Q3	$391K	Buy	23,528 +6,485	+38%	+$125K	0.01%	484
2021 Q2	$416K	Buy	+17,043	New	+$385K	0.02%	456
2015 Q1	–	Sell	-8,136	Closed	-$258K	–	492
2014 Q4	$258K	Buy	+8,136	New	+$231K	0.02%	443
2014 Q2	$477K	Buy	+21,131	New	+$441K	0.04%	384
2013 Q4	$948K	Sell	37,920 -3,975	-9%	-$93.8K	0.1%	210
2013 Q3	$1.15M	Sell	41,895 -13,750	-25%	-$287K	0.12%	177
2013 Q2	$1.01M	Buy	+55,645	New	+$766K	0.12%	172